about
Influence of diabetes mellitus on heart failure risk and outcomeThe risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studiesImprovement of Diabetic Patients Nursing Care by the Development of Educational ProgramsRegulation of cardiomyocyte hypertrophy in diabetes at the transcriptional levelGene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes.Therapeutic potential of endothelin receptor antagonists in diabetes.Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type II diabetic mice.Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malmö preventive project studyEndothelins in chronic diabetic complications.Causes and characteristics of diabetic cardiomyopathy.Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans.Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.RAGE and its ligands: a lasting memory in diabetic complications?Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapyRAGE and modulation of ischemic injury in the diabetic myocardiumDiastolic dysfunction: a link between hypertension and heart failure.Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.Diabetic Cardiomyopathy: An Immunometabolic Perspective.Obesity-related cardiorenal disease: the benefits of bariatric surgery.DPP4 inhibitors and cardiovascular outcomes: safety on heart failure.Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity.Redox regulation of Ito remodeling in diabetic rat heart.Insulin regulation of glutathione and contractile phenotype in diabetic rat ventricular myocytes.Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator.Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus.PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice.Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E.[ESC/EASD joint guidelines on diabetes and cardiovascular diseases].Exercise restores coronary vascular function independent of myogenic tone or hyperglycemic status in db/db mice.Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.Left ventricular size and function in patients with noninsulin-dependent diabetes and postinfarction total or subtotal coronary occlusions.Intrauterine growth restriction coupled with hyperglycemia: effects on cardiac structure in adult rats.Aerobic interval training reduces inducible ventricular arrhythmias in diabetic mice after myocardial infarction.
P2860
Q24800363-78719A20-B960-43AA-B732-AC32E69B22D9Q26999933-06B34ACE-D15D-4C38-8266-5A626839898AQ27021867-E03D0F96-5CD9-4DDE-AE04-D65573E18F44Q28580101-8C3652EF-96B9-4D93-9E07-1FF7B6B0CAD6Q33489603-14CA26B5-981A-478C-BE57-5333C9F1D9C1Q33711031-0FA93279-44B9-4415-9897-6ECA431140B2Q34024314-81BAC476-C7DD-4B20-A4C7-1DB392FEF94FQ34090982-213DA018-75EC-4F98-92B6-91CD9FB1E64EQ34340227-8F5CAA75-E00B-4A0F-BB02-ADA5165F57B3Q34372508-2B0BD87D-1758-4D30-A7E9-62820BEA4ABDQ34782910-4BEED413-0031-497F-9BFF-DC9146BF85A6Q35168430-4D1437DD-02B4-4471-A1E2-E1B6F377DCF7Q35612808-0C498124-B66B-4970-9391-EC9B6093DCA8Q35953956-665FDDEE-2F1A-48C7-A218-0B479B1DEF54Q36216817-5DA609FF-535F-4DFC-893E-37242B9C5E2FQ36320548-27B1729E-4CB5-438A-A543-25F8D382E15EQ36720290-F5415C79-0EE9-43D3-8A25-CFF390A7509FQ36756482-26362343-BB7D-4FA9-95F0-7F74BF820164Q37270165-9AE49F1D-4903-4CFC-8131-1D4AEAF95DCCQ37457580-678CAD53-4ACA-4E02-A69E-01C536CB538EQ37741735-1575FA65-B322-4B94-B6A2-4D2C779A1759Q38126800-EF5129E8-A850-4BDD-9FE2-42631FF2D734Q38833312-81568529-2239-4EDB-9462-57B2F2FA86ACQ42466673-584A8263-BDAA-4F11-A0EA-A205D968831EQ42470417-9603CE4A-9D37-4AEA-849C-515C8784D3B3Q42503082-5216191F-4ADD-4A25-8677-3DA4C5FDFF73Q44103914-4BB4D081-A79C-49F8-AE9A-78E1A95ABC16Q44191957-13FDF731-14D5-4344-B277-98DB40CB6566Q44477014-A0659E2D-CCAA-40EE-A5F4-9A61B633436EQ44612931-CB01027B-578B-400D-82F7-35A05BA491B8Q44643868-5214B52D-174F-4B56-8BA0-B7E2964305E7Q44705248-FC8F02BE-E63C-4711-BDD4-66D7F5317CF8Q44846601-F5B2B3AA-5D27-4DED-ACAB-022EB716F280Q45042361-CC5FEDF3-500F-432F-9BE6-BCAB7CA57534Q46123308-D692F27E-92D6-454B-9D7F-3E34E87D82B3Q46473206-7323888D-EF2F-46AB-BF80-923C01CD2C55Q47214520-DBBF0E85-A617-460B-840B-7F82CF16D0A2Q47274326-F0F3123B-2BCB-46C1-A389-5E31693832F7Q50795680-A666235B-41FE-4D93-AA81-2272B450D731Q52661325-6D6E6883-2025-444D-8EDF-28FE80659A5D
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Cardiac consequences of diabetes mellitus.
@en
type
label
Cardiac consequences of diabetes mellitus.
@en
prefLabel
Cardiac consequences of diabetes mellitus.
@en
P2860
P356
P1433
P1476
Cardiac consequences of diabetes mellitus.
@en
P2093
P2860
P304
P356
10.1002/CLC.4960180604
P577
1995-06-01T00:00:00Z